Your browser is no longer supported. Please, upgrade your browser.
Settings
CRMD CorMedix, Inc. daily Stock Chart
CRMD [NYSE]
CorMedix, Inc.
Index- P/E- EPS (ttm)-1.18 Insider Own1.30% Shs Outstand24.91M Perf Week-2.03%
Market Cap180.60M Forward P/E- EPS next Y-1.61 Insider Trans457.50% Shs Float22.76M Perf Month7.57%
Income-21.80M PEG- EPS next Q-0.22 Inst Own16.70% Short Float16.03% Perf Quarter-13.69%
Sales0.60M P/S301.00 EPS this Y49.70% Inst Trans22.53% Short Ratio7.54 Perf Half Y-0.68%
Book/sh0.72 P/B10.07 EPS next Y-70.20% ROA-145.20% Target Price20.50 Perf Year353.13%
Cash/sh1.05 P/C6.89 EPS next 5Y- ROE- 52W Range1.03 - 13.70 Perf YTD12.40%
Dividend- P/FCF- EPS past 5Y15.20% ROI-244.20% 52W High-47.08% Beta2.75
Dividend %- Quick Ratio6.20 Sales past 5Y192.70% Gross Margin-4.40% 52W Low600.48% ATR0.53
Employees22 Current Ratio6.30 Sales Q/Q605.30% Oper. Margin- RSI (14)50.68 Volatility8.68% 7.59%
OptionableYes Debt/Eq0.39 EPS Q/Q66.90% Profit Margin- Rel Volume0.52 Prev Close7.15
ShortableNo LT Debt/Eq0.39 EarningsMay 13 AMC Payout- Avg Volume483.81K Price7.25
Recom2.00 SMA204.47% SMA50-6.03% SMA200-0.70% Volume251,810 Change1.40%
Mar-26-19Reiterated H.C. Wainwright Buy $3 → $15
Dec-06-18Initiated ROTH Capital Buy $6
Sep-25-17Reiterated H.C. Wainwright Buy $3 → $4
Aug-10-17Reiterated Rodman & Renshaw Buy $5 → $3
May-05-17Reiterated Rodman & Renshaw Buy $6 → $5
Nov-11-16Reiterated FBR & Co. Outperform $6 → $4
Mar-17-16Reiterated FBR Capital Outperform $7 → $6
Mar-03-16Initiated FBR Capital Outperform $7
Nov-16-15Reiterated ROTH Capital Neutral $2.75 → $2.50
Oct-29-15Reiterated ROTH Capital Neutral $4.50 → $2.75
May-06-15Downgrade ROTH Capital Buy → Neutral $2.50 → $7.50
Dec-08-14Reiterated ROTH Capital Buy $3 → $2.50
Oct-03-11Downgrade Maxim Group Buy → Hold
Jun-10-19 08:30AM  CorMedix Inc. to Ring NYSE Closing Bell on Monday, June 10 GlobeNewswire +16.54%
May-31-19 06:48PM  Edited Transcript of CRMD earnings conference call or presentation 13-May-19 8:30pm GMT Thomson Reuters StreetEvents
May-16-19 08:45AM  CorMedix Inc. to Present at the 20th Annual B. Riley FBR Institutional Investor Conference GlobeNewswire
May-13-19 05:45PM  CorMedix (CRMD) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:41PM  CorMedix: 1Q Earnings Snapshot Associated Press
04:05PM  CorMedix Inc. Reports First Quarter 2019 Financial Results and Provides Business Update GlobeNewswire
May-10-19 08:15AM  Cormedix Announces Presentation of LOCK-IT-100 Study Results at National Kidney Foundation Spring 2019 Meeting GlobeNewswire
May-08-19 09:07AM  Should You Take Comfort From Insider Transactions At CorMedix, Inc. (NYSEMKT:CRMD)? Simply Wall St.
May-06-19 08:15AM  CorMedix Inc. to Report First Quarter 2019 Financial Results and Provide a Corporate Update on May 13 GlobeNewswire
Apr-22-19 08:15AM  CorMedix Announces Online Pre-Clinical Abstract at the Upcoming Annual Meeting of American Society of Clinical Oncology GlobeNewswire +5.91%
Apr-17-19 08:00AM  CorMedix Completes Sale of $5.4 Million of NOL Tax Benefits Through New Jersey Economic Development Authority Program GlobeNewswire
Apr-11-19 04:15PM  CorMedix Notified of Compliance with NYSE American Listing Requirements ACCESSWIRE
Apr-02-19 08:05AM  Is CorMedix, Inc. (NYSEMKT:CRMD) Overpaying Its CEO? Simply Wall St. +5.07%
Mar-26-19 07:36AM  The Daily Biotech Pulse: Japanese Cheer For AbbVie, Myokardia Offering, CytomX CFO Departs Benzinga -8.19%
Mar-25-19 04:15PM  CorMedix Confirms Previously Announced One-For-Five Reverse Stock Split ACCESSWIRE
Mar-21-19 08:30AM  CorMedix Inc. Announces Appointment of Phoebe Mounts as Executive Vice President and General Counsel ACCESSWIRE +9.15%
Mar-14-19 04:05PM  CorMedix Inc. Reports Fourth Quarter And Full-Year 2018 Financial Results, Announces Reverse Stock Split And Provides Business Update ACCESSWIRE
Mar-11-19 04:35PM  CorMedix Inc. to Present at Roth and Oppenheimer & Co. Investor Conferences ACCESSWIRE
10:30AM  Will CorMedix (CRMD) Report Negative Q4 Earnings? What You Should Know Zacks
Mar-07-19 08:00AM  CorMedix Inc. to Report Year Ended December 31, 2018 Financial Results on Thursday, March 14 ACCESSWIRE +6.21%
Mar-04-19 08:00AM  CorMedix Inc. Appoints Alan W. Dunton, M.D. to Board of Directors ACCESSWIRE
Feb-21-19 07:20AM  Research Report Identifies SS&C Technologies, Allergan plc, CorMedix, The Allstate, Vedanta, and Lexicon Pharmaceuticals with Renewed Outlook Fundamental Analysis, Calculating Forward Movement GlobeNewswire
Feb-20-19 08:00AM  Biotech Bounce Just Getting Started ACCESSWIRE
Feb-14-19 01:47PM  Here's Why CorMedix Dropped as Much as 27.1% Today Motley Fool -27.94%
08:15AM  CorMedix Inc. Announces FDA Meeting Update ACCESSWIRE
Feb-13-19 09:00AM  Biotech and Cannabis Stocks That Are Emerging ACCESSWIRE -6.79%
Feb-12-19 02:25PM  These Healthcare Stocks Could Surpass Investor Expectations ACCESSWIRE +24.41%
Jan-30-19 08:15AM  Cormedix Inc. Announces Topline Analysis of the Full Data Set of Phase 3 Lock-It-100 Study Reinforces the Interim Results ACCESSWIRE +5.62%
Jan-29-19 07:35AM  Factors of Influence in 2019, Key Indicators and Opportunity within The Hain Celestial Group, Allegheny Technologies, NVR, Greif, CorMedix, and Enzo Biochem New Research Emphasizes Economic Growth GlobeNewswire
Jan-21-19 08:41AM  Options Traders Expect Huge Moves in CorMedix (CRMD) Stock Zacks
Jan-17-19 09:26AM  These 4 Healthcare Stocks Are Raising Expectations ACCESSWIRE
08:00AM  Cormedix Inc. Announces Highly Statistically Significant Topline Results For Neutrolin(R) From The Interim Analysis Of The Phase 3 Lock-It-100 Study ACCESSWIRE
Jan-16-19 04:15PM  CorMedix Inc. Announces Resignation of Member of Its Board of Directors ACCESSWIRE
08:00AM  Today's Research Reports on Trending Tickers: Incyte and CorMedix ACCESSWIRE
Jan-09-19 06:30AM  This Stock Generated 25X Returns In Just Five Years: Could BTCY Be At The Same Crossroads? ACCESSWIRE
Jan-03-19 03:15PM  Cormedix Announces Closing of $7.5 Million Senior Secured Convertible Debt Financing ACCESSWIRE
Dec-21-18 08:58AM  Implied Volatility Surging for CorMedix (CRMD) Stock Options Zacks -8.80%
Dec-11-18 09:00AM  CBD and Biotech Plays on The Rise ACCESSWIRE
Dec-10-18 03:10PM  Cormedix Receives Approval to Sell $5.4 Million of NOL Tax Benefits Through the New Jersey Economic Development Authority Program ACCESSWIRE
Nov-28-18 11:50AM  Biomedical Trends Fuel New Momentum For Healthcare Stocks; Premier Health Group, Inc. (OTC: PHGRF) (CSE: PHGI), Alliqua BioMedical, BioScrip, Coremedix ACCESSWIRE +11.67%
08:10AM  Consolidated Research: 2018 Summary Expectations for Kadmon, Overstock, AECOM, Steelcase, CorMedix, and Corindus Vascular Robotics Fundamental Analysis, Key Performance Indications GlobeNewswire
Nov-27-18 11:00AM  CBD and Biotech Stocks to Watch ACCESSWIRE -7.69%
Nov-15-18 03:28PM  CorMedix: 3Q Earnings Snapshot Associated Press -17.69%
Nov-14-18 03:10PM  CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update ACCESSWIRE
Nov-06-18 03:00PM  CorMedix Inc. to Report Third Quarter 2018 Financial Results on Wednesday, November 14 ACCESSWIRE
Nov-02-18 11:20AM  3 Healthcare Stocks Using Technology To Boost Growth ACCESSWIRE +20.95%
Nov-01-18 08:30AM  Penny Stocks to Buy Using Technical Analysis for November 2018 Investopedia
Oct-18-18 09:15AM  Recent Analysis Shows Lantheus, Editas Medicine, CorMedix, DXP Enterprises, Peabody Energy, and CommScope Holding Market Influences Renewed Outlook, Key Drivers of Growth GlobeNewswire -15.79%
08:00AM  CorMedix Inc. Clarifies That No New Shares Are Being Issued In Connection With Its Recently Filed Form S-3 Registration Statement ACCESSWIRE
Oct-01-18 07:13AM  What Kind Of Shareholders Own CorMedix Inc (NYSEMKT:CRMD)? Simply Wall St. +22.85%
Aug-31-18 04:15PM  CorMedix Announces NYSE American Acceptance of Plan to Regain Listing Compliance ACCESSWIRE +5.44%
Aug-30-18 08:00AM  CorMedix Inc. to Present at The 20th Annual Rodman & Renshaw Global Investment Conference ACCESSWIRE +7.52%
Aug-27-18 07:40AM  Analysis: Positioning to Benefit within C&J Energy Services, LivePerson, Kadmon, Cara Therapeutics, CorMedix, and Second Sight Medical Products Research Highlights Growth, Revenue, and Consolidated Results GlobeNewswire +9.44%
Aug-14-18 06:09PM  CorMedix: 2Q Earnings Snapshot Associated Press -8.20%
04:05PM  CorMedix Inc. Reports Second Quarter Financial Results and Provides Business Update ACCESSWIRE
02:30PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Aug-02-18 08:00AM  CorMedix Inc. to Report Second Quarter 2018 Financial Results on Tuesday, August 14 ACCESSWIRE +15.37%
Jul-26-18 08:10AM  Today's Research Reports on Stocks to Watch: USANA Health Sciences and CorMedix ACCESSWIRE +31.90%
Jul-25-18 07:30AM  Cormedix Inc. Announces Positive Results Of Its Neutrolin(R) Phase 3 Lock-It-100 Study Based On Recommendation By Independent Data Safety Monitoring Board ACCESSWIRE +16.43%
Jul-24-18 07:55AM  Free Research Reports on CorMedix and Three More Biotech Stocks ACCESSWIRE
Jun-26-18 07:30AM  Report: Exploring Fundamental Drivers Behind Chegg, C.H. Robinson Worldwide, Republic Services, CorMedix, Burlington Stores, and Etsy New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
Jun-25-18 07:05AM  Today's Free Research Reports Coverage on CorMedix and Three More Biotech Stocks ACCESSWIRE -6.37%
Jun-20-18 07:30AM  Cormedix Inc. Completes Review and Source Verification of Phase 3 Lock-It 100 Data For Neutrolin(R) ACCESSWIRE
Jun-19-18 04:15PM  Cormedix Inc. Receives a Continued Listing Standard Notice from the NYSE American ACCESSWIRE
May-30-18 08:35AM  Benzinga Pro's 5 Stocks To Watch Today Benzinga +23.78%
May-29-18 04:30PM  CorMedix, Inc. Reports Progress on LOCK- IT 100 Data Review and Appoints Paul Chew as Consultant Advisor CMO ACCESSWIRE
May-25-18 04:25PM  With A -26.58% Earnings Drop, Did CorMedix Inc (NYSEMKT:CRMD) Really Underperform? Simply Wall St. +5.39%
May-15-18 04:05PM  Cormedix Inc. Reports First Quarter Financial Results and Provides Business Update ACCESSWIRE
May-09-18 08:20AM  Report: Exploring Fundamental Drivers Behind CorMedix, U.S. Silica, Zoetis, Kansas City Southern, Bemis, and Flowserve New Horizons, Emerging Trends, and Upcoming Developments GlobeNewswire
08:00AM  CorMedix Inc. to Report First Quarter 2018 Financial Results on Tuesday, May 15 ACCESSWIRE
Apr-27-18 08:00AM  CorMedix Revises Timeline and Announces Changes to Lock-It-100 Study Management ACCESSWIRE +6.51%
Mar-20-18 05:00PM  CorMedix Inc. Makes NYSE American Section 610(b) Public Announcement ACCESSWIRE -12.63%
Mar-19-18 04:05PM  Cormedix Inc. Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Business Update ACCESSWIRE -6.11%
12:00PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Mar-13-18 08:00AM  CorMedix Inc. to Report Fourth Quarter and Full Year 2017 Financial Results on Monday, March 19 ACCESSWIRE
Mar-07-18 08:25AM  Investor Expectations to Drive Momentum within AVEO Pharmaceuticals, PTC Therapeutics, NGL Energy Partners LP, Bemis, CorMedix, and Patterson Companies Discovering Underlying Factors of Influence GlobeNewswire
Feb-27-18 09:15AM  CorMedix Inc. Provides Update on Its Financing Plans in Connection with Its Ongoing LOCK-IT 100 Clinical Study ACCESSWIRE
Feb-26-18 08:00AM  CorMedix Inc. Granted Orphan Drug Designation for Taurolidine for Treatment of Neuroblastoma ACCESSWIRE -5.90%
Feb-20-18 01:53PM  Why CorMedix Inc. (CRMD) Shares Took a Nosedive Today SmarterAnalyst -32.19%
07:30AM  CorMedix Inc. Achieves Target Number of Events in Its LOCK-IT-100 Study of Neutrolin(R) for Interim Efficacy Analysis ACCESSWIRE
Jan-01-18 11:31AM  ETFs with exposure to CorMedix, Inc. : January 1, 2018 Capital Cube
Dec-27-17 08:43AM  CorMedix, Inc. :CRMD-US: Earnings Analysis: Q3, 2017 By the Numbers : December 27, 2017 Capital Cube
Dec-19-17 12:35PM  ETFs with exposure to CorMedix, Inc. : December 19, 2017 Capital Cube
Dec-07-17 01:22PM  ETFs with exposure to CorMedix, Inc. : December 7, 2017 Capital Cube
Dec-05-17 08:05AM  CorMedix Inc. Announces Acceptance of Final Post-Marketing Study Data to be Published in the European Journal of Clinical Microbiology and Infectious Diseases ACCESSWIRE
Dec-04-17 04:20PM  CorMedix Inc (CRMD): Should The Recent EPS Drop Worry You? Simply Wall St. +17.60%
Nov-29-17 08:05AM  CorMedix Inc. to Host Seminar on Hemodialysis Catheter Complications at 17th Annual Conference on Nephrology ACCESSWIRE
Nov-20-17 08:20AM  CorMedix Inc. Announces Common Stock Purchase by Company Directors and Executive Management Team ACCESSWIRE
Nov-13-17 08:00AM  Factors of Influence in 2018, Key Indicators and Opportunity within CorMedix, RPC, Royal Caribbean Cruises, Callaway Golf, CIT Group, and Cars.com New Research Emphasizes Economic Growth GlobeNewswire -7.36%
Nov-09-17 04:15PM  CorMedix Inc. Reports Third Quarter Financial Results and Provides Business Update ACCESSWIRE
04:15PM  CorMedix Inc. Enters into $5 Million Combined Securities Purchase and Backstop Agreement with Existing Investor ACCESSWIRE
12:05PM  CorMedix Inc. to Host Earnings Call ACCESSWIRE
Nov-07-17 10:04AM  ETFs with exposure to CorMedix, Inc. : November 7, 2017 Capital Cube
08:05AM  CorMedix Inc. to Report Third Quarter 2017 Financial Results and Provide Business Update ACCESSWIRE
Oct-26-17 04:07PM  CorMedix Inc. to Present Candida auris Susceptibility Data at 2nd Annual Gulf Congress of Clinical Microbiology and Infectious Diseases ACCESSWIRE
Oct-12-17 10:23AM  ETFs with exposure to CorMedix, Inc. : October 12, 2017 Capital Cube -9.51%
Oct-11-17 07:34PM  Is There Now An Opportunity In CorMedix Inc (CRMD)? Simply Wall St. +15.76%
Sep-28-17 08:05AM  CorMedix Inc. to Present at The MicroCap Conference ACCESSWIRE
Sep-25-17 08:05AM  CorMedix Inc. Relocates Corporate Headquarters ACCESSWIRE
Sep-21-17 12:15PM  CorMedix Inc. to Present at The MicroCap Conference on October 5th in New York City at the Essex House ACCESSWIRE
CorMedix, Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. It primarily focuses on the development of its lead product candidate, Neutrolin, an anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as dialysis, critical/intensive care, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix, Inc. was founded in 2006 and is based in Berkeley Heights, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dillione JanetDirectorMay 15Buy6.7411,14475,11147,326May 17 09:24 AM
Cook Robert W.Chief Financial OfficerMar 29Buy9.3510093525,517Apr 01 04:49 PM
Baluch KhosoChief Executive OfficerMar 26Buy7.552,50018,87552,575Mar 27 04:15 PM
ARMSTRONG JR. JOHN L.Exec VP of Tech OperationsMar 26Buy7.735,00038,65069,378Mar 27 04:12 PM
ARMSTRONG JR. JOHN L.Exec VP of Tech OperationsMar 25Buy1.6915,00025,350321,890Mar 25 04:09 PM
Kaplan MyronDirectorMar 22Buy1.6520,00033,000493,666Mar 22 04:06 PM
Dillione JanetDirectorMar 18Buy1.6742,00069,972180,909Mar 20 04:21 PM
ARMSTRONG JR. JOHN L.Exec VP of Tech OperationsDec 31Option Exercise0.0018,0290306,890Jan 03 04:02 PM
Lefkowitz Steven WDirectorDec 20Buy1.1820,00023,500135,757Dec 21 04:19 PM
Khan MehmoodDirectorDec 20Buy1.24100,000124,410564,583Dec 21 04:16 PM
Kaplan MyronDirectorDec 14Buy1.4750,00073,300431,166Dec 17 04:01 PM
Masson ElizabethEVP, Head of Clinical Ops.Dec 05Option Exercise0.2940,00011,60040,000Dec 06 04:19 PM
ARMSTRONG JR. JOHN L.Exec VP of Tech OperationsNov 29Buy1.45250,000363,150288,861Nov 30 04:04 PM
Baluch KhosoChief Executive OfficerNov 27Buy1.2121,50026,015250,373Nov 27 04:55 PM
Cook Robert W.Chief Financial OfficerNov 27Buy1.1725,00029,213127,083Nov 27 04:53 PM
Baluch KhosoChief Executive OfficerNov 26Buy1.283,5004,480228,873Nov 27 04:55 PM
Kaplan MyronDirectorNov 23Buy1.3050,00064,795371,166Nov 27 04:19 PM
Kaplan MyronDirectorNov 06Option Exercise0.005,0000321,166Nov 27 04:08 PM
Gelbfish Gary A.DirectorOct 12Option Exercise1.051,000,0001,050,0003,101,121Oct 16 05:07 PM